48,466
edits
Difference between revisions of "Prostate cancer with neuroendocrine differentiation"
Jump to navigation
Jump to search
Prostate cancer with neuroendocrine differentiation (view source)
Revision as of 16:31, 19 March 2018
, 16:31, 19 March 2018tweak
(split out) |
(tweak) |
||
| Line 1: | Line 1: | ||
''' | '''Prostate cancer with neuroendocrine differentiation''' is a rare group of [[prostate cancer]]s that is hypothesized to evolve in the context androgen deprivation therapy.<ref name=pmid24705311>{{Cite journal | last1 = Epstein | first1 = JI. | last2 = Amin | first2 = MB. | last3 = Beltran | first3 = H. | last4 = Lotan | first4 = TL. | last5 = Mosquera | first5 = JM. | last6 = Reuter | first6 = VE. | last7 = Robinson | first7 = BD. | last8 = Troncoso | first8 = P. | last9 = Rubin | first9 = MA. | title = Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. | journal = Am J Surg Pathol | volume = 38 | issue = 6 | pages = 756-67 | month = Jun | year = 2014 | doi = 10.1097/PAS.0000000000000208 | PMID = 24705311 }}</ref> | ||
'''Neuroendocrine carcinoma of the prostate''' redirect here. | |||
==Subclassification== | |||
It is subclassified as per Epstein ''et al.'':<ref name=pmid24705311/> | It is subclassified as per Epstein ''et al.'':<ref name=pmid24705311/> | ||
*Usual prostate adenocarcinoma with neuroendocrine differentiation. | *Usual prostate adenocarcinoma with neuroendocrine differentiation. | ||